Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Editorial

Neural Networks in Neurological and Psychiatric Diseases

Author(s): Felix-Martin Werner

Volume 25 , Issue 4 , 2019

Page: [374 - 375] Pages: 2

DOI: 10.2174/138161282504190516080951

[1]
Ahumada-Pascual P, García-Ganan D, Berdei-Montero Y, Velasco A. Fatty acids and antioxidants in multiple sclerosis: Therapeutic role of GEMSP. Curr Pharm Des 2019; 25(4): 376-80.
[2]
Tomasetti C, Montemitro C, Fiengo ALC, et al. Novel pathways in the treatment of major depression: focus on the glutamatergic system. Curr Pharm Des 2019; 25(4): 381-7.
[3]
Werner F-M, Covenas R. Therapeutic effect of novel antidepressant drugs acting at specific receptors of neurotransmitters and neuropeptides. Curr Pharm Des 2019; 25(4): 388-95.
[4]
Werner F-M, Covenas R. Neural networks in generalized epilepsy and novel antiepileptic drugs. Curr Pharm Des 2019; 25(4): 396-400.

© 2022 Bentham Science Publishers | Privacy Policy